RedHill Biopharma (RDHL) Posts Q3 Loss of 7c/Share
RedHill Biopharma (NASDAQ: RDHL) reported Q3 EPS of ($0.07), $0.51 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.
RedHill Biopharma (NASDAQ: RDHL) reported Q3 EPS of ($0.07), $0.51 better than the analyst estimate of ($0.58).
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.